Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database

Journal of Clinical Oncology

Volumn 24, Issue 19, 2006, Pages 2998-3006

  Lally, Brian E ^a   Zelterman, Daniel ^b   Colasanto, Joseph M ^b   Haffty, Bruce G ^b   Detterbeck, Frank C ^b   Wilson, Lynn D ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DATA BASE; FEMALE; HUMAN; LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL; TUMOR VOLUME; ADJUVANT THERAPY; CANCER REGISTRY; COHORT ANALYSIS; FACTUAL DATABASE; LUNG TUMOR; LYMPH NODE METASTASIS; MIDDLE AGED; PATHOLOGY; PATIENT SELECTION; RETROSPECTIVE STUDY; STATISTICS; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PATIENT SELECTION; PNEUMONECTOMY; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SEER PROGRAM; SURVIVAL ANALYSIS;

EID: 33745999736     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.04.6110     Document Type: Article

References (20)

1. The Lung Cancer Study Group: Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. N Engl J Med 315:1377-1381, 1986
2. PORT Meta-analysis Trialists Group: Postoperative radiotherapy in non-small-cell lung cancer: Systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet 352:257-263, 1998
3. Burdett S, Stewart L: Postoperative radiotherapy in non-small-cell lung cancer: Update of an individual patient data meta-analysis. Lung Cancer 47:81-83, 2005
4. Mayer R, Smolle-Juettner FM, Szolar D, et al: Postoperative radiotherapy in radically resected non-small cell lung cancer. Chest 112:954-959, 1997
5. Dautzenberg B, Arriagada R, Chammard AB, et al: A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma: Groupe d'Etude et de Traitement des Cancers Bronchiques. Cancer 86:265-273, 1999
6. Henson DE, Bores-Saavedra J: Checking up on the surveillance, epidemiology, and end results program. J Natl Cancer Inst 96:1050-1051, 2004
7. Field RW, Smith BJ, Platz CE, et al: Lung cancer histologic type in the surveillance, epidemiology, and end results registry versus independent review. J Natl Cancer Inst 96:1105-1107, 2004
8. Yano T, Yokoyama H, Inoue T, et al: Surgical results and prognostic factors of pathologic N1 disease in non-small-cell carcinoma of the lung: Significance of N1 level - Lobar or hilar nodes. J Thorac Cardiovasc Surg 107:1398-1402, 1994
9. Okada M, Tsubota N, Yoshimura M, et al: Prognosis of completely resected pN2 non-small cell lung carcinomas: What is the significant node that affects survival? J Thorac Cardiovasc Surg 118:270-275, 1999
10. Rescigno J: Use of postoperative radiotherapy for node-positive non-small-cell lung cancer. Clin Lung Cancer 4:35-44, 2002
11. Bogart JA, Aronowitz JN: Localized non-small cell lung cancer: Adjuvant radiotherapy in the era of effective systemic therapy. Clin Cancer Res 11:5004s-5110s, 2005
12. Bonner JA: The role of postoperative radiotherapy for patients with completely resected non-small cell lung carcinoma: Seeking to optimize local control and survival while minimizing toxicity. Cancer 86:195-196, 1999
13. Munro AJ: What now for postoperative radiotherapy for lung cancer? Lancet 352:250-251, 1998
14. Arriagada R, Bergman B, Dunant A, et al: Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 350:351-360, 2004
15. Strauss GM, Herndon J, Maddaus MA, et al: Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small cell lung cancer (NSCLC). J Clin Oncol 22:621s, 2004 (suppl; abstr 7019)
16. Winton T, Livingston R, Johnson D, et al: Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 352:2589-2597, 2005
17. Sawyer TE, Bonner JA, Gould PM, et al: Effectiveness of postoperative irradiation in stage IIIA non-small cell lung cancer according to regression tree analyses of recurrence risks. Ann Thorac Surg 64:1402-1407, 1997
18. Machtay M, Lee JH, Shrager JB, et al: Risk of death from intercurrent disease is not excessively increased by modern postoperative radiotherapy for high-risk resected non-small-cell lung carcinoma. J Clin Oncol 19:3912-3917, 2001
19. Keller SM, Adak S, Wagner H, et al: A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer: Eastern Cooperative Oncology Group. N Engl J Med 343:1217-1222, 2000
20. Bradley JD, Paulus R, Graham MV, et al: Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: Promising long-term results of the Radiation Therapy Oncology Group - RTOG 9705. J Clin Oncol 23:3480-3487, 2005